From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
Empowering the healthcare sector to confidently test and treat hepatitis B
Providing reliable advice on hepatitis B testing and treatment through clinical practice tools and guidelines
Connecting healthcare professionals to specialists for expert support and education
Collaborating with people living with hepatitis B to produce resources promoting inclusive care free of stigma
Healthcare workers who have completed hepatitis B training with ASHM
Hepatitis B courses delivered
Decision Making In Hepatitis B clinical tool Downloads
The fourth edition of “B Positive: All you wanted to know about hepatitis B – a guide for primary care providers” has been updated to align with the most recent Australian consensus recommendations for the management of hepatitis B (2022).
Enhance your clinical decision-making in hepatitis B management with this comprehensive resource. Stay updated and follow the guide to inform decisions in hepatitis B care by accessing this decision making guide.
The Viral Hepatitis Mapping Project aims to improve understanding of chronic hepatitis B (CHB) and C (CHC) in Australia by examining regional variations in prevalence and care uptake.
From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs (HSD) Program will be removed.
As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment.
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM